Skip to main content

Table 3 MIC for the seventeen carbapenem resistant Klebsiella pneumoniae strains

From: The emergence of carbapenem resistant Klebsiella pneumoniae in Malaysia: correlation between microbiological trends with host characteristics and clinical factors

Strains

Antibiotics (MIC range in μg/ml)

 

aTGC

(≤1: S, >2: R)

TC

(≤4: S, 8 = I, ≥16: R)

FX

(≤8: S, 16 = I, ≥32: R)

CT

(≤1: S,

2 = I, ≥4: R)

TZ

(≤4: S, 8 = I, ≥16: R)

TX

(≤1: S,

2 = I, ≥4: R)

PM

(≤2: S, 4-8 = SDD, ≥16: R)

IP

(≤1: S, 2 = I, ≥4: R)

MP

(≤1: S,

2 = I, ≥4: R)

ETP

(≤0.5: S, 1 = I, ≥2: R)

GM

(≤4: S, 8 = I, ≥16: R)

TM

(≤4: S, 8 = I, ≥16: R)

AK

(≤16: S, 32 = I, ≥64: R)

AT

(≤4: S, 8 = I, ≥16: R)

CI

(≤1: S, 2 = I, ≥4: R)

LE

(≤2: S, 4 = I, ≥8: R)

aCT

(≤2: S, >2: R)

K/1310-23

2

>256

>256

>256

>256

>256

>256

1.5

6

8

>256

>256

32

>256

>32

>32

1.5

K/1311-36

4

256

>256

256

>256

>256

>256

1.5

>32

6

0.094

0.19

0.5

>256

0.047

0.25

0.19

K/1308-12

1

>256

>256

>256

>256

>256

>256

>32

>32

>32

>256

48

24

>256

>32

>32

0.38

K/1312-3

2

>256

2

>256

>256

>256

24

1

6

16

0.38

1.5

256

48

>32

8

0.125

K/1310-33

0.75

>256

128

>256

48

>256

>256

>32

>32

>32

>256

>256

64

>256

>32

>32

0.06

K/1311-35

0.38

6

1.5

4

32

8

0.38

6

0.64

0.094

0.125

0.125

3

24

0.125

0.5

0.19

K/1312-17

0.75

>256

128

6

1

4

16

>32

>32

>32

>256

128

3

0.125

>32

>32

0.125

AN9

1.5

>256

48

4

0.38

2

1

>32

>32

>32

>256

8

3

0.19

>32

>32

0.125

K/1309-5

0.38

>256

>256

>256

128

>256

>256

2

>32

>32

>256

>256

24

>256

>32

>32

0.19

K/1310-24

0.5

>256

2

0.75

0.19

1.5

1.5

6

>32

6

0.19

0.19

1

0.047

0.5

0.5

0.125

KLEB 2013-105

0.19

>256

64

>256

128

>256

>256

>32

>32

>32

96

>256

24

>256

>32

>32

0.25

K/1309-18

0.75

>256

>256

6

0.5

3

2

>32

>32

>32

>256

6

4

0.25

>32

>32

0.25

K/1309-39

0.25

>256

>256

>256

>256

>256

64

12

>32

16

>256

>256

>256

>256

>32

>32

0.125

K/1304-16

1

>256

3

64

192

>256

24

4

0.064

0.125

>256

>256

>256

192

>32

>32

0.125

K/1309-38

0.19

>256

>256

>256

128

>256

>256

4

>32

>32

>256

24

12

>256

>32

>32

0.38

K/1311-26

1

>256

6

1

0.75

1

3

4

>32

24

>256

64

24

0.125

>32

>32

0.38

K/1310-35

0.25

6

3

0.75

0.094

1

0.125

3

>32

0.75

0.125

0.25

2

0.047

0.023

0.125

0.19

  1. TGC Tigecycline, TC Tetracycline, FX Cefoxitin, CT Cefotaxime, TZ Ceftazidime, TX Ceftriaxone, PM Cefepime, IP Imipenem, MP Meropenem, ETP Ertapenem, GM Gentamicin, TM Tobramycin, AK Amikacin, AT Aztreonam, CI Ciprofloxacin, LE Levofloxacin, CT Colistin, S Sensitive, I Intermediate, R Resistant, SDD Susceptible-dose dependent
  2. All MIC values were interpreted using CLSI, 2015 guidelines unless noted otherwise. aMIC values were interpreted based on EUCAST breakpoints, 2016